SCHOTT Pharma AG & Co. KGaA | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Headlines Articles Press releases SCHOTT Pharma AG & Co. KGaA

Home
Companies
SCHOTT Pharma AG & Co. KGaA

BRIEF

published on 09/26/2024 at 12:35, 1 month 24 days ago

SCHOTT Pharma, Gerresheimer, and Stevanato Group Form “Alliance for RTU”

Drug Containment Pharmaceutical Efficiency RTU Alliance Operational Risk Sterile Packaging
PRESS RELEASE

published on 09/26/2024 at 12:30, 1 month 24 days ago

SCHOTT Pharma, Gerresheimer, and Stevanato Group announce strategic industry “Alliance for RTU”
SCHOTT Pharma, Gerresheimer, and Stevanato Group form Alliance for RTU, advancing ready-to-use containers for pharmaceutical manufacturing efficiency and patient safety

SCHOTT Pharma Gerresheimer Pharmaceutical Manufacturing Stevanato Group Alliance For RTU
BRIEF

published on 09/05/2024 at 07:05, 2 months 16 days ago

SCHOTT Pharma Listed on MDAX for the First Time

Frankfurt Stock Exchange Growth Targets Market Confidence MDAX Inclusion Drug Containment
PRESS RELEASE

published on 09/05/2024 at 07:00, 2 months 16 days ago

Promotion for SCHOTT Pharma: Listed on the MDAX for the first time
SCHOTT Pharma AG & Co. KGaA to be included in the MDAX index, marking a significant milestone. Company continues to expand and strengthen market position

Market Position SCHOTT Pharma Growth Targets MDAX Share Listing
BRIEF

published on 08/29/2024 at 07:05, 2 months 23 days ago

SCHOTT Pharma Delivers Strong Third Quarter Results and Raises FY 2024 Revenue Guidance

Innovation Revenue Growth EBITDA Margin High-value Solutions Expansion Projects
PRESS RELEASE

published on 08/29/2024 at 07:00, 2 months 23 days ago

SCHOTT Pharma delivers strong third quarter results and raises FY 2024 revenue guidance
SCHOTT Pharma reports strong Q3 results with 21% revenue growth, EBITDA margin of 28.2%, and raises FY 2024 revenue guidance. Strategic focus on innovation and growth projects

Innovation Revenue Growth FY 2024 Guidance SCHOTT Pharma Q3 Results
BRIEF

published on 08/08/2024 at 16:25, 3 months 12 days ago

SCHOTT Pharma Aligns Climate Actions with Paris Agreement Goals

Decarbonization Climate Action Green Electricity GHG Emissions Paris Agreement
PRESS RELEASE

published on 08/08/2024 at 16:20, 3 months 12 days ago

SCHOTT Pharma reinforces commitment to align its climate actions to the requirements of the Paris Agreement
SCHOTT Pharma reinforces commitment to align its climate actions with the Paris Agreement, validated by Science Based Targets initiative. Focus on emission reduction and technological innovation

SCHOTT Pharma Emission Reduction Science Based Targets Paris Agreement Climate Actions
BRIEF

published on 07/31/2024 at 10:10, 3 months 21 days ago

SCHOTT Pharma Unveils Enhanced Nest Design for Polymer Syringes

Cost Reduction Sustainable Design Pharma Efficiency Polymer Syringes High-tech Collaboration
PRESS RELEASE

published on 07/31/2024 at 10:05, 3 months 21 days ago

Transforming operational efficiency and sustainability: SCHOTT Pharma introduces nest design with more cavities for prefillable polymer syringes
SCHOTT Pharma introduces nest design holding 160 syringes, increasing efficiency by up to 67% while reducing manufacturing costs and carbon footprint by 17%

Sustainability Operational Efficiency SCHOTT Pharma Prefillable Polymer Syringes Nest Design

1 2 ... 4

Accesswire

Published on 11/21/2024 at 10:03, 39 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 42 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 42 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 7 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 17 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 12 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 37 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 40 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 42 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 42 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 44 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 22 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 57 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 57 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE